Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food

Completed

Conditions studied: Type 2 Diabetes, Currently Taking Metformin

In brief

This study will look at the impact that meals have on blood glucose (sugar) levels. Subjects will be asked to use a Continuous Glucose Monitoring System (CGM), which monitors glucose levels continuously. Breakfast and lunch meals will be provided and must be consumed at the International Diabetes Center.

Key facts

Study ID

NCT00818077

Run by

HealthPartners Institute

People needed

15

Starts

2008-01-01

Expected to finish

2010-09-01

Last updated by the study team

2015-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Female or male
• Age 18 and older
• Diagnosed with type 2 diabetes for a minimum of 6 months
• Is taking metformin for diabetes management; no other diabetes medications
• Has been on a stable dose of metformin for at least 3 months
• HbA1c is 7% or greater and less than 9%; >7% or <9%
• BMI <30kg/m2
• Willing to give informed consent
• No evidence of acute illness, fever, undue stress
• Motivated and capable of following the protocol and instructions provided by the healthcare professional
• Available for the study on the scheduled visit days
• Access to telephone communications

You may not qualify if…

• Under 18 years of age
• Has not been diagnosed with type 2 diabetes for a minimum of 6 months
• Is currently taking other diabetes medications in addition to metformin
• Has taken other diabetes medications within the past 3 months
• HbA1c <7% or >9%
• BMI > 30kg/m2
• Unable to follow the study protocol
• No access to telephone communications
• Unable to read and write in English
• Unable to maintain their health, or have undue stress
• Skin abnormalities at the insertion sites that would confound assessment of the effect of the device on the skin
• Allergy to adhesives
• Any concomitant medical condition that would likely affect the evaluation of device performance
• Taken oral or inhaled prednisone or cortisone medications in the previous 30 days

Where it is running

• International Diabetes Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.